The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus
Dermato · 2021
DOI: 10.3390/dermato1020009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermato, 2021. Verfasst von Karolina Krawczyk und 4 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
About 20% of patients with systemic sclerosis have symptoms of another connective tissue disease (CTD). Interstitial lung disease (ILD) is one of the most common organ manifestations in systemic sclerosis (SSc) as well as viral illnesses, such as COVID-19, and can lead not only to diffuse alveolar damage, but also trigger an exacerbation of fibrosis among patients with preexisting ILD. It is also associated with substantial morbidity and mortality. According to the World Scleroderma Foundation, SSc-ILD can mask or mimic early COVID-19 lesions and there are no available computed tomography guidelines on how to discern those two conditions. We present a case of systemic sclerosis exacerbation after COVID-19 in a patient with SSc-Lupus Overlap Syndrome.
Zitieren
APA
Krawczyk, K., Mazur, E., Kargol, J., Kijowski, R., & Reich, A. (2021). The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus. Dermato. https://doi.org/10.3390/dermato1020009
Vancouver
Krawczyk K, Mazur E, Kargol J, Kijowski R, Reich A. The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus. Dermato. 2021. doi:10.3390/dermato1020009
BibTeX
@article{Krawczyk2021,
author = {Krawczyk, Karolina and Mazur, Ewelina and Kargol, Jaromir and Kijowski, Robert and Reich, Adam},
title = {The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus},
journal = {Dermato},
year = {2021},
doi = {10.3390/dermato1020009}
}
EUVIMED